'''(-)-1-Phenyl-2-propylaminopentane''' (also known as '''(-)-PPAP''' and '''N,α-dipropylphenethylamine''')<ref>{{cite web | url=https://www.google.com/patents/US5220068 | title=Patent US 5220068 - Psychostimulant agent | date=15 June 1993 | author=Jozsef Knoll}}</ref><ref>{{cite web | url=https://www.google.com/patents/US6214859 | title=Patent US 6214859 - Ethylamine derivatives | date=10 April 2001 | author=Fumio Yoneda}}</ref><ref>{{cite web | url=https://www.google.com/patents/US5075338 | title=Patent US 5075338 - Method of treatment of learning deficiency | date=24 December 2001 | author=Jozsef Knoll}}</ref> is a [[stimulant]] of the [[Substituted phenethylamine|phenethylamine]] and [[Substituted amphetamine|amphetamine]] classes with an unusual effects profile and mechanism of action.<ref>{{cite journal | title=The pharmacology of 1-phenyl-2-propylamino-pentane (PPAP), a deprenyl-derived new spectrum psychostimulant. |vauthors=Knoll J, Knoll B, Török Z, Timár J, Yasar S | journal=Archives internationales de Pharmacodynamie et de Thérapie | date=March–April 1992 | issue=316 | pages=5–29 | pmid=1356324}}</ref>
